Bottom line
CGVIX vs TRGLX: the short answer
CGVIX (Causeway Global Value Fund) and TRGLX (T. Rowe Price Global Stock Fund) are both mutual funds.
But TRGLX is far broader, holding 138 positions to 61 for CGVIX, so beyond the top names it adds exposure CGVIX doesn't have.
TRGLX is cheaper at 0.66% vs 0.85% — a difference of $19 a year per $10,000 invested.
Over five years, CGVIX returned +14.9% a year vs +12.3% for TRGLX (reporting dates differ).
Updated Nov 19, 2026
CGVIX vs TRGLX side by side
| CGVIX | TRGLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Causeway Capital Management | T. Rowe Price |
| Category | Global Stock | Global Stock |
| Expense ratio | 0.85% | 0.66% |
| Annual cost per $10k | $85 | $66 |
| 10-yr cost on $10k (prospectus) | $1,350 | $822 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +33.9% | +17.0% |
| 5-yr return (annualized) | +14.9% | +12.3% |
| 10-yr return (annualized) | +11.4% | — |
| Best quarter | +34.0% | +31.1% |
| Worst quarter | −35.0% | −20.4% |
| Net assets (fund) | $270.8M | $8.3B |
| Number of holdings | 61 | 138 |
| Portfolio turnover | 68% | 172% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
CGVIX and TRGLX share none of their top holdings.
CGVIX top 10
- Kering Sa — 4.14%
- Alaska Air Group, Inc. — 3.84%
- Renesas Electronics Corporation — 3.82%
- Carrier Global Corporation — 3.66%
- Tencent Holdings Limited — 3.12%
- Live Nation Entertainment, Inc. — 2.98%
- Sap Se — 2.85%
- Merck & Co., Inc. — 2.85%
- Alstom Sa — 2.65%
- Astrazeneca Plc — 2.62%
TRGLX top 10
- Nvidia Corp — 5.60%
- Taiwan Semiconductor Manufac — 3.53%
- Apple Inc — 3.23%
- Alphabet Inc Cl A — 2.90%
- Microsoft Corp — 2.50%
- Unitedhealth Group Inc — 2.39%
- Amazon.com Inc — 2.33%
- Asml Holding Nv — 2.24%
- Unilever Plc — 2.20%
- Broadcom Inc — 2.19%
FAQ
What is the difference between CGVIX and TRGLX?
Which is cheaper, CGVIX or TRGLX?
Should I own both CGVIX and TRGLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.